Regulation & Compliance

The Identity & Access Forum's 2026 committee will tackle digital ID's biggest challenges, from accelerating mobile driver's licenses to fighting fraud.

A venture in Brazil's agricultural heartland will use blockchain and AI to create 'Digital Green Passports,' promising transparency but facing huge hurdles.

A major clinical trial setback for a promising liver disease drug leaves patients waiting and puts Bausch Health's future strategy under scrutiny.

Youlife Group plans to acquire Anlian HR, a key OMO player, in a strategic move to build an end-to-end ecosystem for China's vast blue-collar workforce.

Swiss biotech GeNeuro suspends trading, awaiting a critical court ruling on its debt moratorium that will decide its fate and the future of its novel drugs.

Vietnam partners with industry leaders to launch compliant crypto payments for tourists, a key step in its ambitious International Financial Center plan.

Blue Owl Capital faces a securities fraud lawsuit after a failed merger and stock drops. Investors allege the firm hid liquidity issues and BDC risks.

A landmark survey of TRREB's 70,000 members reveals widespread calls for transparency and reform as the board navigates a brutal housing market.

In Gartner's first-ever Magic Quadrant for QMS, European vendor Fabasoft stands out with its AI-driven platform and commitment to data privacy.

London's Ellipses Pharma in-licenses a novel B7H3 antibody-drug conjugate from Innolake, aiming to outmaneuver competitors with a unique payload.

21shares launches its Dogecoin ETF on NASDAQ, marking a new chapter for the meme coin, but it enters a crowded field with significant investor risks.

Applied Research Associates promotes Maggie Gendron, a DC insider, signaling a strategic push to align its advanced tech with national defense and infrastructure priorities.

Wirex's 2025 Transparency Report details its fight against financial crime, but also candidly reveals the challenges of customer account freezes.

SPR Therapeutics unveils 12-month data at NANS 2026, showing its temporary SPRINT PNS system provides durable pain relief without a permanent implant.

As providers face growing financial risk and complex rules, Roji's 19-year CMS certification highlights the critical role of trusted data partners.

With a $30M investment, Balance Homes offers a co-ownership model to help homeowners unlock equity amid record debt and tight credit.

A detox facility's new campaign reveals a surge in addiction to kratom, a legal but unregulated substance causing opioid-like dependency across California.

With its Drone Nerds acquisition and a new board member, XTI Aerospace is signaling a major pivot from VTOL development to the booming drone market.

Royal Bank of Canada is urging its shareholders to reject an unsolicited offer from TRC Capital, calling it a below-market bid designed to trap unwary investors.

A new telehealth pharmacy offers flat-rate annual pricing for compounded weight loss drugs, challenging high costs but raising questions about regulation.